Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study

BMC Endocrine Disorders

Volumn 12, Issue , 2012, Pages

  Lu, Shou En ^a   Beckles, Gloria L ^b   Crosson, Jesse C ^c   Bilik, Dorian ^d   Karter, Andrew J ^e   Gerzoff, Robert B ^b   Lin, Yong ^a   Ross, Sonja V ^c   McEwen, Laura N ^d   Waitzfelder, Beth E ^f,g   Marrero, David ^h   Lasser, Norman ⁱ   Brown, Arleen F ^j  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e DIVISION OF RESEARCH   (United States)

^f PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^g Kaiser Center for Health Research Hawaii   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE DURATION; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROSPECTIVE STUDY;

EID: 84863516040     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-12     Document Type: Article

References (51)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979, 2(2):120-126. 10.2337/diacare.2.2.120, 520114.
2. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992, 20(3):736-744. 10.1016/0735-1097(92)90033-J, 1512357.
3. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001, 101(6):671-679.
4. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847. 10.1161/01.CIR.97.18.1837, 9603539.
5. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991, 83(1):356-362. 10.1161/01.CIR.83.1.356, 1984895.
6. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286(2):180-187. 10.1001/jama.286.2.180, 11448281.
7. Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007, 30(5):1292-1293. 10.2337/dc06-1358, 17290036.
8. Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care 2009, 32(4):708-713. 10.2337/dc08-1918, 2660447, 19114615.
9. van Dieren S, Peelen LM, Nothlings U, van der Schouw YT, Rutten GE, Spijkerman AM, van der AD, Sluik D, Boeing H, Moons KG, et al. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 2011, 54(2):264-270. 10.1007/s00125-010-1960-0, 3017299, 21076956.
10. Donnan PT, Donnelly L, New JP, Morris AD. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population. Diabetes Care 2006, 29(6):1231-1236. 10.2337/dc05-1911, 16732001.
11. Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S, Grobbee DE, Neal B, et al. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010, 53(5):821-831. 10.1007/s00125-010-1681-4, 20157695.
12. van Dieren S, Beulens JW, Kengne AP, Peelen LM, Rutten GE, Woodward M, van der Schouw YT, Moons KG. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart 2012, 98(5):360-369. 10.1136/heartjnl-2011-300734, 22184101.
13. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009, 26(2):142-148. 10.1111/j.1464-5491.2008.02640.x, 19236616.
14. Timbie JW, Hayward RA, Vijan S. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med 2010, 170(12):1037-1044. 2897053, 20585069.
15. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24(11):987-1003. 10.1016/S0195-668X(03)00114-3, 12788299.
16. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007, 335(7611):136. 10.1136/bmj.39261.471806.55, 1925200, 17615182.
17. Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 2010, 341:c6624. 10.1136/bmj.c6624, 2999889, 21148212.
18. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297(6):611-619. 10.1001/jama.297.6.611, 17299196.
19. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998, 97(18):1876-1887. 10.1161/01.CIR.97.18.1876, 9603549.
20. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110(2):227-239. 10.1161/01.CIR.0000133317.49796.0E, 15249516.
21. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update) [Cited 17 November 2011]; Available from:www.nice.org.uk/nicemedia/pdf/CG66FullGuideline0509.pdf.
22. Cardiovascular disease-primary prevention [Cited 17 November 2011]; Available from: www.bcguidelines.ca/gpac/pdf/cvd.pdf.
23. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28(1):88-136.
24. van der Heijden AA, Ortegon MM, Niessen LW, Nijpels G, Dekker JM. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care 2009, 32(11):2094-2098. 10.2337/dc09-0745, 2768197, 19875606.
25. Davis WA, Colagiuri S, Davis TM. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust 2009, 190(4):180-184.
26. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev 2011, 123(4):e18-e209.
27. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000, 139(2 Pt 1):272-281.
28. The Translating Research Into Action for Diabetes (TRIAD) study; a multicenter study of diabetes in managed care. Diabetes Care 2002, 25(2):386-389.
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. 10.1016/0021-9681(87)90171-8, 3558716.
30. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 2003, 56(3):221-229. 10.1016/S0895-4356(02)00585-1, 12725876.
31. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15(4):361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
32. Harrell FE. Regression modeling strategies : with applications to linear models, logistic regression, and survival analysis 2001, Springer, New York.
33. Hosmer DW, Lemeshow S. Applied logistic regression 2000, Wiley, New York, 2.
34. van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med 2000, 19(24):3401-3415. 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2, 11122504.
35. May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal 1998, 4(2):109-120. 10.1023/A:1009612305785, 9658770.
36. Raghunathan T, Lepkowski J, van Hoewyk J, Solenberger P. A MultivariateTechnique for Multiply Imputing Missing Values Using a Sequence of Regression Models. Survey Methodology 2001, 27(1):85-95.
37. Raghunathan T, Solenberger P, Van Hoewyk J. IVEware: Imputation and variance estimation software user guide 2002, Survey Research Center, Institute for Social Research, Ann Arbor, MI.
38. Rubin DB. Multiple Imputation for Nonresponse in Surveys 1987, Wiley & Sons, New York.
39. Prospective UK. Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991, 34(12):877-890.
40. Ahluwalia SC, Gross CP, Chaudhry SI, Leo-Summers L, Van Ness PH, Fried TR. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med 2011, 26(10):1145-1151. 10.1007/s11606-011-1725-6, 21573881.
41. Ahluwalia SC, Gross CP, Chaudhry SI, Ning YM, Leo-Summers L, Van Ness PH, Fried TR. Impact of Comorbidity on Mortality Among Older Persons with Advanced Heart Failure. J Gen Intern Med 2012, 27((5)):513-519.
42. Merikangas KR, Ames M, Cui L, Stang PE, Ustun TB, Von Korff M, Kessler RC. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry 2007, 64(10):1180-1188. 10.1001/archpsyc.64.10.1180, 2248275, 17909130.
43. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999, 100(10):1134-1146. 10.1161/01.CIR.100.10.1134, 10477542.
44. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007, 115(1):114-126.
45. Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH, Mohiuddin SM, Ockene IS, Taylor CB, Wenger NK. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002, 105(14):1735-1743. 10.1161/01.CIR.0000013074.73995.6C, 11940556.
46. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010, 56(25):e50-e103. 10.1016/j.jacc.2010.09.001, 21144964.
47. Brown AF, Ettner SL, Piette J, Weinberger M, Gregg E, Shapiro MF, Karter AJ, Safford M, Waitzfelder B, Prata PA, et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev 2004, 26:63-77. 10.1093/epirev/mxh002, 15234948.
48. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004, 44(2):198-206. 10.1053/j.ajkd.2004.04.024, 15264177.
49. Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010, 170(12):1024-1031. 10.1001/archinternmed.2010.182, 20585067.
50. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, Gaziano JM, Frishman WH, Curb JD. Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 2004, 160(12):1152-1158. 10.1093/aje/kwh314, 15583367.
51. Centres for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, Department of Health and Human Services, Centres for Disease Control and Prevention, 2011, Atlanta, GA: US, [Cited 7 June 2011]; Available from:http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.